Therapy development for epilepsy and rare diseases
What we do
We are a boutique consultancy specialized in therapy development for epilepsy and rare neurodevelopmental disorders. Our team has been working on developmental and epileptic encephalopathies (DEEs) since before the term was coined, giving us unique perspective on how the field has evolved.
Within this niche, we support biopharma across the full value chain, from strategy to preclinical, clinical, regulatory, and communications. Over two decades, we have built a trusted network that helps our clients open doors, anticipate stakeholder needs, and build credibility in a complex ecosystem.
From seed-stage biotech to global pharma, we help teams make critical decisions at every stage of therapy development. Discover our services below.
Pipeline and portfolio strategy
Clinical and regulatory development support
Medical Affairs, communications and patient engagement
Featured publications
Recent insights
Featured
La doceava edición del Foro CDKL5 tuvo lugar en Londres, los días 26 y 27 de octubre de 2026. El Foro es una reunión anual que organiza la Fundación Loulou y en la que científicos y miembros de la industria farmacéutica se reúnen con representantes de la comunidad de pacientes para repasar los últimos avances en el campo.
Este es un repaso para los grupos de pacientes de las principales novedades del Foro CDKL5 2026.